Chronic protocols could show more long-term beneficial effects of leptin receptor blockade on blood pressure and/or highlight the detrimental effects of leptin inhibition on obesity and SDB. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.